期刊文献+

多巴敏感性肌张力障碍一家三例报告 被引量:3

Report of three cases of dopa-responsive dystonia in one family
下载PDF
导出
摘要 目的 :认识多巴敏感性肌张力障碍的临床特征 ,以期早期诊治。方法 :描述我院发现的一家 3例患者的临床表现、实验室检查及治疗效果。结果 :男 2例 ,女 1例 ,系同代兄妹。可记忆发病年龄在 10岁左右 ,隐袭发病 ,缓慢进展 ,均以语速变快 ,肢体僵硬 ,不自主运动等锥体外系表现为特征 ,症状白天有波动。体检 3例均有肌张力铅管样增高 ,腱反射活跃 ,2例有畸形足。 3例均无 Babinski征。辅助检查头颅 CT、MRI、血清肌酶谱、神经电生理等均正常。给予美多巴 0 .12 5~ 0 .3 75 g/ d治疗均有显著疗效。使用最长者达 3 0年 (早期用左旋多巴 ) ,未见不良反应。结论 :多巴敏感性肌张力障碍发病率低、但有特征表现 。 Objective: To study the clinical characteristics of dopa responsive dystonia (DRD),providing data for earlier diagnosis and treatment. Methods: Three cases of DRD patients from the same family were studied through their clinical data, laboratory investigations and therapeutic effects. Results: Two males and one female were the same generation. The age of onset remembered was about 10 years. The symptoms were insidiously progressive. Clinical features were extrapyramidal presentations such as fast words speed, limbs stiffness and involuntary movements. All 3 patients had leadtube muscle rigidity, exaggerated tendon reflexes; Two patients had feet deformity. Babinski signs were absent.CT, MRI, serum muscular enzymes and EMG, etc . were normal. Madopa,0.125 0.375 g, daily was effective with the longest treatment period for nearly 30 years and no obvious side effects found. Conclusion: The incidence of DRD is rare with specific presentations, early diagnosis and treatment may achieve better results.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2002年第3期333-334,共2页 Academic Journal of Second Military Medical University
关键词 肌张力障碍 多巴敏感性 左旋多巴 遗传学 dystonia,dopa responsive levodopa
  • 相关文献

参考文献2

二级参考文献3

共引文献31

同被引文献13

  • 1朱文梅,罗德儒.伴有明显昼间变化的进行性肌张力障碍一家四例报告[J].中华神经精神科杂志,1994,27(4):227-229. 被引量:20
  • 2Ichinose H, Ohye T, Matsuda Y, et al. Characterization of mouse and human GTP cyclohydrolase I genes mutations in patients with GTP eyclohydrolase I deficiency. J Biol Chern, 1995, 270 ( 17 ) :10062.
  • 3Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsire dystonia and sepiapterin reductase deficiency. Mol Genet Metab, 2001,74 : 172.
  • 4Nygaard TG, Masden CD, Duvoism RC. Dopa-responsive dystonia. Adv Neurol, 1988,50 : 377.
  • 5Chen RS, Huang CC, Lu CS. Dopa-responsive dystonia: clinical and family study in Taiwan Residents. Clin Neurol Neurosurg, 1996,98:43.
  • 6Torbjoem G, Nygaard MD, Marsden CD, et al. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology, 1991,41 : 174.
  • 7Hyland K, Fryburg JS, Wilson WG, et al. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology, 1997,48:1290.
  • 8Bonafe L, Thony B, Leimbacher W, et al. Diagnosis of Dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolima in fibroblasts, Clin Chem, 2001,47(3) :477.
  • 9Steinberger D,Korinthenberg R,Topka H, et al. Dopa- responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. Neurology, 2000,55 : 1735.
  • 10陈嵘,梁秀龄,李洵桦,陈理娥,金伟军,张影如,胡平,孙中武.多巴反应性肌张力障碍七例报告[J].中华神经科杂志,1999,32(2):102-104. 被引量:21

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部